KCT0005826尚未招募未知
Clinical study to evaluate the effect of external factor on the composition of intestinal microbiota after oral administration of microbiome in healthy subject
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •[Group of Obesity]
- •(1)A healthy adult who is 19 ~50 years old at the screening test
- •(2)Body mass index (BMI) greater than 25.0 kg / m^2
- •? Body Mass Index (BMI) = body weight (kg) / height (m)^2
- •(3)A person who have no congenital or chronic disease within the last 3 years and have no pathological symptoms or findings as a result of medical examination
- •(4) A person who has bowel movements of Bristol Stool form scale Type 3-5 more than 3 times a week
- •(5) A person who has been judged to be suitable for the test subject to be tested at screening such as laboratory tests (hematology test, blood chemistry test, urine test, etc.) and electrocardiogram test conducted according to the characteristics of medicines
- •(6) A person who signed the written consent to participate in this study with full understanding of the purpose and contents of the examination prior to taking the test
- •(7) A person who has the ability and willingness to participate in the study
- •[Group of elderly]
- •(1)A healthy adult who is 50 years old or older at the screening test
- •(2)Body mass index (BMI) greater than 18.0 kg / m^2 and less than 25.0 kg / m^2 and body weight greater than 45 kg
- •? Body Mass Index (BMI) = body weight (kg) / height (m)^2
- •(3)A person who have no congenital or chronic disease within the last 3 years and have no pathological symptoms or findings as a result of medical examination
- •(4) A person who has bowel movements of Bristol Stool form scale Type 3-5 more than 3 times a week
- •(5) A person who has been judged to be suitable for the test subject to be tested at screening such as laboratory tests (hematology test, blood chemistry test, urine test, etc.) and electrocardiogram test conducted according to the characteristics of medicines
- •(6) A person who signed the written consent to participate in this study with full understanding of the purpose and contents of the examination prior to taking the test
- •(7) A person who has the ability and willingness to participate in the study
- •[Reference Group]
- •(1)A healthy adult who is 19 ~50 years old at the screening test
- •(2)Body mass index (BMI) greater than 18.0 kg / m^2 and less than 25.0 kg / m^2 and body weight greater than 45 kg
- •? Body Mass Index (BMI) = body weight (kg) / height (m)^2
- •(3)A person who have no congenital or chronic disease within the last 3 years and have no pathological symptoms or findings as a result of medical examination
- •(4) A person who has bowel movements of Bristol Stool form scale Type 3-5 more than 3 times a week
- •(5) A person who has been judged to be suitable for the test subject to be tested at screening such as laboratory tests (hematology test, blood chemistry test, urine test, etc.) and electrocardiogram test conducted according to the characteristics of medicines
- •(6) A person who signed the written consent to participate in this study with full understanding of the purpose and contents of the examination prior to taking the test
- •(7) A person who has the ability and willingness to participate in the study
排除标准
- •(1) A person with evidence or evidence of clinically significant blood, kidney, endocrine, respiratory, gastrointestinal, urinary, cardiovascular, liver, mental, neurological or allergic disease (except for asymptomatic seasonal allergies at the time of administration)
- •(2) A person with a history of gastrointestinal disorders (esophageal ataxia or esophageal strictures, Crohn's disease) or surgery (except for simple cecal surgery or hernia surgery) that can affect the absorption of drugs
- •(3) Patients with a history of hypersensitivity to the drug and additives of probiotics or lactic acid bacteria preparetations or other drug(aspirin, antibiotics, etc) and food containing components
- •(4) Screening If you have a regular alcohol intake history of more than 210 g/week within 6 months (10 g of beer (5%) = 10 g, 1 glass of soju (20%) = 8 g , Wine (12%), 1 cup (125 mL) = 12 g)
- •(5) Smokers within 3 months of screening
- •(6) Anyone with a history of major alcohol or drug abuse within a year of screening
- •(7) A person who is at risk of serious adverse/chronic medical, mental, or laboratory examinations that may increase the risk due to the administration of medicines for clinical trials and participation in testing, or may interfere with the interpretation of test results
- •(8) A person who is being treated with steroid drugs
- •(9) A person who took antibiotics within 3 months of the first administration of investigational product
- •(10) A person who took a proton pump inhibitor (PPI) within 1 month prior to the first administration of investigational product
- •(11) A person who took prebiotics or probiotics within 1 month prior to the first administration of investigational product (including yogurt products)
- •(12) A person who took immunosuppressants
- •(13) Pregnant and lactating women
- •(14) A person who have unusual eating habits (e.g. grapefruit juice of 1 L or more per day) or are unable to eat the diet provided in this study
- •(15) A person who is not willing or able to comply with the guidelines for administering the subjects described in this study protocol
- •(16) Anyone deemed to be unfit for participation in this examination, as determined by the tester
研究者
相似试验
已完成
Unknown
A clinical study for evaluating of the effect of a supplement containing plant extract on the gut microbiome. -A Randomized, Double-blind, Placebo controlled, parallel-group StudyHealthy subjects with a tendency for constipationJPRN-UMIN000047224FUKUOKA KINEN PET KENSHIN CENTER30
已完成
不适用
A clinical study for evaluating of the effect of a complex food on postprandial serum triglyceride.JPRN-UMIN000029484Iryouhoujinsyadan Shoureikan Shinsapporo Seiryou Hospital40
已完成
不适用
A clinical study for evaluating the effects of the combined administration of L-citrulline and L-arginine on blood arginine and NOx levelsoneJPRN-UMIN000016647Soiken Inc.40
尚未招募
2 期
To Study the effect of goghruta pratimarsha nasya on krodha in middle age agroup by using clinical anger scale.CTRI/2023/12/060399Dr Shruti Bhatulkar
尚未招募
Unknown
A safe ayurvedic drop which contains Sariva and Yashtimadhu for the dry eye conditions.CTRI/2023/08/056318RAJASHREE BANGAR